scispace - formally typeset
N

Nora D. Volkow

Researcher at National Institute on Drug Abuse

Publications -  1038
Citations -  121498

Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.

Papers
More filters
Journal ArticleDOI

Dopamine Transporters in Striatum Correlate with Deactivation in the Default Mode Network during Visuospatial Attention

TL;DR: The findings suggest that dopamine modulates attention in part by regulating neuronal activity in posterior parietal cortex including precuneus and cingulate gyrus and that the beneficial effects of stimulant medications reflect in part their ability to facilitate the deactivation of the DMN.
Journal ArticleDOI

Personality traits and vulnerability or resilience to substance use disorders

TL;DR: It is argued for the study of endophenotypes within the frame of individual differences, and three high-order personality traits that are tied to specific brain systems and genes are identified that offer a tractable approach to studying SUD.
Journal ArticleDOI

Neuroscience of Addiction: Relevance to Prevention and Treatment

TL;DR: Advances in understanding of brain development and of the role of genes and environment on brain structure and function have built a foundation on which to develop more effective tools to prevent and treat substance use disorder.
Journal ArticleDOI

Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse

TL;DR: The findings suggest that these HIV patients may benefit from treatments that enhance dopamine function or protection from dopamine cell injury, and that reduced dopaminergic function may contribute to cognitive dysfunction in HIV patients with or without additional cocaine abuse.
Journal ArticleDOI

Relationship of Dopamine Type 2 Receptor Binding Potential With Fasting Neuroendocrine Hormones and Insulin Sensitivity in Human Obesity

TL;DR: Evidence is provided for an association between the neuroendocrine hormones and DA brain signaling in obese females and the increased D2R availability in obese subjects reflects relatively reduced DA levels competing with the radioligand.